Presence and origin of large amounts of d-proline in the urine of mutant mice lacking d-amino acid oxidase activity

被引:0
作者
Kenji Hamase
Sayaka Takagi
Akiko Morikawa
Ryuichi Konno
Akira Niwa
Kiyoshi Zaitsu
机构
[1] Kyushu University,Graduate School of Pharmaceutical Sciences
[2] Dokkyo Medical University,Department of Microbiology
[3] International University of Health and Welfare,Center for Medical Science
来源
Analytical and Bioanalytical Chemistry | 2006年 / 386卷
关键词
Column-switching; HPLC; Fluorescence derivatization; Chiral separation; -Proline; -Amino acid oxidase;
D O I
暂无
中图分类号
学科分类号
摘要
Using a column-switching HPLC system combining a micro-ODS column and a chiral column, the amounts of d-proline (d-Pro) have been determined in 18 tissues, plasma and urine of mice. To avoid the enzymatic degradation of d-amino acids in vivo, a mutant mouse strain lacking d-amino acid oxidase activity (ddY/DAO− mouse) was used. In the brain, relatively large amounts of d-Pro were observed in the anterior pituitary, posterior pituitary and pineal glands. In the peripheral tissues, the amounts of d-Pro were high in the pancreas and kidney. Above all, it is surprising that the ddY/DAO− mice excreted large amounts of d-Pro in their urine (433 nmol/mL, 20 times that of l-Pro). The origin of d-Pro has also been investigated. By comparing germ-free mice and gnotobiotic mice, intestinal bacteria were shown to have no effect on the urinary d-Pro amount. Concerning the dietary origin, a notable amount of d-Pro was still excreted in the urine after starvation for 4 days, suggesting that some of the d-Pro is produced in the mice. Age-dependent changes in the urinary d-Pro amount have also been investigated from the postnatal 1st month up to 12 months, and ddY/DAO− mice were found to excrete large amounts of d-Pro in the urine constantly throughout their lives.
引用
收藏
页码:705 / 711
页数:6
相关论文
共 118 条
[1]  
Fujii N(2004)undefined Chem Rec 4 267-278
[2]  
Saito T(2002)undefined J Chromatogr B 781 73-91
[3]  
Hamase K(2002)undefined Orig Life Evol Biosph 32 103-127
[4]  
Morikawa A(2005)undefined Biol Pharm Bull 28 1561-1565
[5]  
Zaitsu K(1997)undefined Prog Neurobiol 52 325-353
[6]  
Fujii N(2000)undefined Neurochem Res 25 553-560
[7]  
Nishikawa T(1995)undefined Proc Natl Acad Sci USA 92 3948-3952
[8]  
Hashimoto A(2005)undefined Biol Pharm Bull 28 1566-1570
[9]  
Oka T(2000)undefined Neuroscience 100 183-189
[10]  
Snyder SH(2000)undefined Endocrinology 141 3862-3870